Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases.

Published

Journal Article

Myocardial revascularization improves survival rates and quality of life for patients with symptomatic ischemic heart disease. The less severe the anatomic disease, the smaller the benefit, particularly for survival. Patients with more severe anatomic disease benefit from surgical therapy, in terms of both survival and quality of life. Continuing advances in pharmacological secondary prevention, percutaneous intervention, and surgical treatment mandate continued analysis of contemporary outcomes to provide the best information for rational decision-making.

Full Text

Duke Authors

Cited Authors

  • Califf, RM; Mark, DB

Published Date

  • April 1, 1994

Published In

Volume / Issue

  • 6 / 2

Start / End Page

  • 120 - 128

PubMed ID

  • 8025138

Pubmed Central ID

  • 8025138

International Standard Serial Number (ISSN)

  • 1043-0679

Language

  • eng

Conference Location

  • United States